Jennifer A. Ligibel, MD, on Weight Loss and Early-Stage Breast Cancer: Impact of Telephone-Based Intervention
Posted: Sunday, June 4, 2023
Jennifer A. Ligibel, MD, of Dana-Farber Cancer Institute, discusses the impact of a telephone-based intervention for weight loss in patients with early-stage breast cancer. In the BWEL trial, adding a telephone-based intervention on weight loss to standard health education resulted in significant weight loss in patients with overweight and obesity. The effects of the weight loss intervention seemed to differ by menopausal status and race/ethnicity.